Estimate-beating fourth-quarter earnings for Amgen Inc. pushed company shares about $7.95 higher to close at $167.53 on Friday as sales of its cholesterol treatment Repatha rose.
To continue reading subscribe now to Latest News
Learn More about Latest News
Already a subscriber? Sign In or Buy now to activate your subscription
